Total Payments
$9,279
2024 Payments
$199.84
Companies
28
Transactions
80
Medicare Patients
5,994
Medicare Billing
$340,765
Payment Breakdown by Category
Research$7,914 (85.3%)
Food & Beverage$1,255 (13.5%)
Education$109.65 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,914 | 6 | 85.3% |
| Food and Beverage | $1,255 | 70 | 13.5% |
| Education | $109.65 | 4 | 1.2% |
Payments by Type
Research
$7,914
6 transactions
General
$1,365
74 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Spectrum Pharmaceuticals Inc. | $7,914 | 6 | $0 (2019) |
| Astellas Pharma US Inc | $325.77 | 15 | $0 (2021) |
| AbbVie Inc. | $115.71 | 7 | $0 (2021) |
| PFIZER INC. | $89.86 | 5 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $81.71 | 5 | $0 (2018) |
| Boston Scientific Corporation | $72.54 | 3 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $62.77 | 4 | $0 (2024) |
| 180 Medical, Inc. | $60.03 | 3 | $0 (2018) |
| UROVANT SCIENCES INC | $59.59 | 4 | $0 (2022) |
| Coloplast Corp | $58.18 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199.84 | 9 | Medtronic, Inc. ($42.57) |
| 2023 | $66.09 | 4 | Olympus America Inc. ($18.42) |
| 2022 | $163.40 | 9 | UROVANT SCIENCES INC ($59.59) |
| 2021 | $149.66 | 6 | Astellas Pharma US Inc ($122.30) |
| 2020 | $11.90 | 1 | Orexo US, Inc. ($11.90) |
| 2019 | $2,673 | 4 | Spectrum Pharmaceuticals Inc. ($2,598) |
| 2018 | $4,313 | 31 | Spectrum Pharmaceuticals Inc. ($3,839) |
| 2017 | $1,702 | 16 | Spectrum Pharmaceuticals Inc. ($1,477) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: HORMONE THERAPY | ||||||
| 08/12/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: UROLOGY | ||||||
| 08/09/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 06/10/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Urology | ||||||
| 06/04/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $42.57 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 03/26/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: rezum_URO | ||||||
| 02/27/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: UROLOGY | ||||||
| 07/10/2023 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Urology Gynecology | ||||||
| 07/07/2023 | Cook Medical LLC | NCIRCLE (Device) | Food and Beverage | Cash or cash equivalent | $15.08 | General |
| Category: Urology | ||||||
| 04/06/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Urology | ||||||
| 03/09/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/08/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $12.00 | General |
| Category: Pain Management | ||||||
| 11/17/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: ONCOLOGY | ||||||
| 11/10/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $15.77 | General |
| Category: Urology | ||||||
| 10/31/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: HORMONE THERAPY | ||||||
| 10/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Oncology | ||||||
| 09/26/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $12.93 | General |
| Category: Urology | ||||||
| 03/03/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $14.47 | General |
| Category: Urology | ||||||
| 01/13/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: Urology | ||||||
| 08/10/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/27/2021 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| 05/19/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: UROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SPI-QAP-306 | Spectrum Pharmaceuticals Inc. | $7,914 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,284 | 1,930 | $162,189 | $74,482 |
| 2022 | 14 | 1,413 | 2,010 | $181,794 | $84,279 |
| 2021 | 18 | 1,622 | 2,336 | $198,090 | $100,418 |
| 2020 | 20 | 1,675 | 2,372 | $188,554 | $81,586 |
Total Patients
5,994
Total Services
8,648
Medicare Billing
$340,765
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 228 | $35,340 | $19,945 | 56.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 230 | $24,380 | $13,383 | 54.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 68 | 83 | $24,900 | $12,490 | 50.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 55 | $9,768 | $6,554 | 67.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $10,422 | $5,826 | 55.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 18 | 18 | $6,084 | $4,160 | 68.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 311 | 559 | $26,832 | $3,832 | 14.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $6,000 | $3,528 | 58.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 23 | 28 | $2,295 | $1,204 | 52.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 12 | 15 | $6,705 | $1,085 | 16.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 259 | 402 | $2,412 | $875.60 | 36.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $1,331 | $686.51 | 51.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 92 | 163 | $1,909 | $501.65 | 26.3% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 18 | 19 | $2,655 | $338.50 | 12.7% |
| 51736 | Simple timed assessment of bladder emptying | Office | 2023 | 15 | 17 | $1,156 | $74.32 | 6.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 193 | 297 | $46,035 | $26,276 | 57.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 76 | 90 | $27,160 | $15,470 | 57.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 207 | $21,942 | $12,652 | 57.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 58 | $10,440 | $7,654 | 73.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $10,422 | $5,983 | 57.4% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 18 | 19 | $6,422 | $4,413 | 68.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 329 | 551 | $26,583 | $3,735 | 14.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 51 | 51 | $6,375 | $3,318 | 52.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 22 | 23 | $10,281 | $1,998 | 19.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 279 | 415 | $2,490 | $906.13 | 36.4% |
About Dr. Lancing Patterson, MD
Dr. Lancing Patterson, MD is a Urology healthcare provider based in Bessemer, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932235900.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lancing Patterson, MD has received a total of $9,279 in payments from pharmaceutical and medical device companies, with $199.84 received in 2024. These payments were reported across 80 transactions from 28 companies. The most common payment nature is "" ($7,914).
As a Medicare-enrolled provider, Patterson has provided services to 5,994 Medicare beneficiaries, totaling 8,648 services with total Medicare billing of $340,765. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Bessemer, AL
- Active Since 02/26/2007
- Last Updated 02/11/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1932235900
Products in Payments
- XTANDI (Drug) $246.37
- FIRMAGON (Drug) $81.71
- GEMTESA (Drug) $77.03
- ORGOVYX (Drug) $48.90
- AVEED (Biological) $48.68
- Androgel (Drug) $46.63
- Noctiva (Drug) $45.00
- INTERSTIM (Device) $42.57
- SPEEDICATH (Device) $41.20
- GENTLECATH (Device) $41.02
- LITHOVUE (Device) $38.40
- VESICARE (Drug) $36.53
- All-In-One (Device) $35.34
- XIAFLEX (Biological) $34.40
- Lithotripters & Accessories (Device) $32.43
- Nubeqa (Drug) $26.21
- BOTOX THERAPEUTIC (Biological) $25.36
- Prolia (Biological) $23.85
- Lupron (Drug) $23.15
- Rezum Generator (Device) $20.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.